Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $0.31.

  • Ekso Bionics Holdings' Debt to Equity rose 1251.1% to $0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.31, marking a year-over-year increase of 1251.1%. This contributed to the annual value of $0.3 for FY2024, which is 2087.4% down from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' Debt to Equity is $0.31, which was up 1251.1% from $0.31 recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Debt to Equity high stood at $0.38 for Q4 2023, and its period low was $0.05 during Q2 2021.
  • Moreover, its 5-year median value for Debt to Equity was $0.23 (2023), whereas its average is $0.21.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Debt to Equity plummeted by 9227.87% in 2021, and later soared by 19482.77% in 2023.
  • Ekso Bionics Holdings' Debt to Equity (Quarter) stood at $0.05 in 2021, then soared by 176.5% to $0.15 in 2022, then surged by 158.88% to $0.38 in 2023, then decreased by 20.87% to $0.3 in 2024, then increased by 2.43% to $0.31 in 2025.
  • Its last three reported values are $0.31 in Q3 2025, $0.31 for Q2 2025, and $0.28 during Q1 2025.